Gather the evidence
AI agents extract variant reports, annotations, inheritance patterns, and disease-specific findings from the literature.
Rare disease AI platform
AI for rare disease discovery.
We help patient foundations and research teams turn fragmented literature, variant data, biological models, and public datasets into mechanism maps that accelerate the path toward treatments.
Variant intelligence
Mechanism mapping
Treatment hypotheses
Understand pathogenic variants
Curate rare disease evidence
Map transcript consequences
Prioritize mechanistic evidence
Connect genetics to phenotype
Empower rare disease organizations
Why Alstara
Rare disease teams need more scientific leverage.
Families need answers. Foundations need credible research plans. Scientists need a way to connect genetic findings to transcripts, proteins, pathways, symptoms, and intervention hypotheses.
Alstara is building an AI platform that helps rare disease teams compress that early discovery cycle while keeping the science inspectable, evidence-backed, and ready for expert review.
Platform
From variant lists to actionable disease biology.
Model molecular impact
Variants are mapped to transcript effects, NMD likelihood, splice disruption, protein constraints, and predicted structural impact.
Connect to phenotype
Mechanistic signals are compared with symptoms, syndromic scores, expression patterns, and disease-relevant tissues.
Prioritize next experiments
Teams get clearer hypotheses, biomarker ideas, pathway candidates, and treatment-relevant research directions.
Scientific operating system
Mechanism mapping for rare disease teams.
The platform is designed around the questions rare disease scientists ask every day: what has been published, what happens to the transcript, what happens to the protein, what changes downstream, and how those findings might explain clinical phenotypes.
Literature
Variant reports, exon context, case evidence
Transcript
NMD, splicing, expression, isoforms
Protein
Structure, constraint, abundance, interactions
Pathway
Networks, perturbation, rescue hypotheses
Who we serve
AI tools for the rare disease organizations closest to the urgency.
Patient foundations
Turn published data and community knowledge into research roadmaps that help families, funders, and advisors align.
Scientific advisors
Review structured evidence, inspect assumptions, and move faster from variant biology to testable hypotheses.
Biotech partners
Evaluate clearer mechanistic and translational cases in rare disease areas that are often overlooked.
Current platform work
Variant case studies that connect genetics to disease biology.
Our early work focuses on AI-assisted workflows for variant literature extraction, predicted transcript consequences, protein-level impact, and downstream pathway mapping.
Build with us
Ready to accelerate rare disease research?
We are speaking with rare disease foundations, scientists, and biotech teams who want to use AI to accelerate discovery while keeping the work rigorous and human-centered.
Contact Alstara